Telocyte seeks to cure Alzheimer's differently

Prior therapies have focused on effects, not on causes. They have tried to help symptoms or wished to remove amyloid or tau proteins.

Research shows that cell aging triggers the gradual accumulation of amyloid, as well as the loss of neurons that defines Alzheimer’s.

Telomerase resets the abnormal pattern of gene expression that results in Alzheimer’s disease. We can make a difference. Join us.

Our Mission

Our mission is not to help anyone “live with Alzheimer’s”, but to ensure that all of us can live without Alzheimer’s. Our mission is to cure Alzheimer’s, plain and simple. We intend to save the lives, the minds, and the souls of those who have Alzheimer’s now and to prevent anyone from getting Alzheimer’s in the future.
Learn more

Introducing Telocyte's founders

  • Michael Fossel, MD, PhD
  • Founder, President
  • Dr. Fossel is the driving force behind Telocyte and has been the leader in proposing the use of telomerase to treat human disease for the past two decades.

  • Read more
  • Peter Rayson
  • Founder, Chief Executive Officer
  • Peter T. Rayson is an experienced industry executive who provides leadership and business acumen for Telocyte.

  • Read more

Telocyte and CNIO MOU

Telocyte and CNIO have signed an MOU for collaboration to investigate the use of Telomerase Therapy to cure Alzheimer’s.

Under the direction of  Dr. Maria Blasco, C.N.I.O. – The Spanish National Research Centre, has recently made advances in both animal research and delivery systems that has facilitated an opportunity to pursue unsurpassed clinical advances in the field of telomerase therapy.  Dr. Blasco   is an internationally recognized expert in the field of telomerase

Read more

Michael Fossel Book and Research

  • The Telomerase Revolution
  • Meant for the general public, this book describes what we know about aging—and how to prevent and reverse age-related diseases using telomerase therapy.
  • Read more
  • EMBO
  • Published in the pre-eminent scientific journal EMBO, this article demonstrated the efficacy of telomerase therapy in treating aging in animals, without any evidence of side effects.

  • Read more